期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Medical and surgical approach to ocular surface reconstruction
1
作者 Daniella Lent-Schochet Asim Dhungana +2 位作者 Inae Jang Kim Hassan Shah Asim V.Farooq 《Annals of Eye Science》 2024年第1期43-59,共17页
Ocular surface disease(OSD)can have a severe impact on patients as it can lead to visual impairment and persistent discomfort.Ocular surface reconstruction(OSR)is an approach to the management of ocular diseases that ... Ocular surface disease(OSD)can have a severe impact on patients as it can lead to visual impairment and persistent discomfort.Ocular surface reconstruction(OSR)is an approach to the management of ocular diseases that cause structural damage to the ocular surface.OSR encompasses both medical and surgical treatment options.In this review,we discuss the medical and surgical strategies used in OSR.Medical management often aims to treat tear insufficiency,inflammation,and keratinization.Surgical treatments may be employed for a variety of reasons,including failure of medical management.This may include improving the oculo-palpebral structures in order to improve lid positioning and tear film.Additional therapies focus on improving tear production,such as through salivary gland transplantation.In situations where the ocular surface is so severely damaged that there is loss of limbal stem cells,limbal stem cell transplant(LSCT)may be indicated.Other surgeries such as amniotic membrane transplant(AMT)and conjunctival flaps(CFs)can help promote corneal healing.Finally,in severe situations where the cornea is beyond salvage,corneal transplantation,such as a penetrating keratoplasty(PKP),can be considered.OSR often requires a combination of medical and surgical approaches targeted to each specific patient’s presentation in order to achieve optimal outcomes. 展开更多
关键词 ocular surface reconstruction(OSR) ocular surface disease(OSD) amniotic membrane transplant(AMT) limbal stem cell transplant(LSCT) eyelid reconstruction
下载PDF
Conjunctival flaps for the treatment of advanced ocular surface disease—looking back and beyond
2
作者 Richard P.Gibralter Vivian S.Hawn 《Annals of Eye Science》 2022年第4期40-49,共10页
Conjunctival flaps have previously proven to be effective in preserving the globe for individuals with severe ocular surface disease.Infectious keratitis,neurotrophic keratitis,nontraumatic corneal melts,descemetocele... Conjunctival flaps have previously proven to be effective in preserving the globe for individuals with severe ocular surface disease.Infectious keratitis,neurotrophic keratitis,nontraumatic corneal melts,descemetoceles,perforations,and corneal burns are all indications for this procedure.The flaps promote nutrition,metabolism,structure,and vascularity,as well as reduce pain,irritation,inflammation,and infection.Furthermore,patients avoid the emotional and psychological repercussions of enucleation or evisceration,while requiring fewer postoperative medications and office visits.Currently,fewer flaps are performed due to the emergence of additional therapeutic techniques,such as serum tears,bandage lenses,corneal grafting,Oxervate,amniotic membrane,and umbilical cord grafting.However,despite newer conservative medical methods,conjunctival flaps have been demonstrated to be useful and advantageous.Moreover,future technologies and approaches for globe preservation and sight restoration after prior conjunctival flaps are anticipated.Herein,we review the history,advantages,and disadvantages of various surgical techniques:Gundersen’s bipedicle flap,partial limbal advancement flap,selective pedunculated conjunctival flap with or without Tenon’s capsule,and Mekonnen’s modified inferior palpebral-bulbar conjunctival flap.The surgical pearls and recommendations offered by the innovators are also reviewed,including restrictions and potential complications.Procedures for visual rehabilitation in selective cases after conjunctival flap are reviewed as well. 展开更多
关键词 Conjunctival flap Gunderson flap ocular surface reconstruction
下载PDF
Amniotic membrane transplantation: an updated clinical review for the ophthalmologist
3
作者 Iyza F.Baig Nhon T.Le Zaina Al-Mohtaseb 《Annals of Eye Science》 2023年第2期26-38,共13页
Although amniotic membrane transplantation(AMT)has long been used as an essential surgical technique for ocular surface reconstruction,its role continues to evolve and expand.In the management of numerous ocular surfa... Although amniotic membrane transplantation(AMT)has long been used as an essential surgical technique for ocular surface reconstruction,its role continues to evolve and expand.In the management of numerous ocular surface disorders,ranging from inflammatory to infectious,traumatic to neoplastic,the ability to perform AMT is a valuable addition to the skillset of any ophthalmologist.The purpose of this paper is to provide ophthalmologists with an updated,evidence-based review of the clinical indications for AMT in corneal and conjunctival reconstruction,reviewing its common and even experimental applications known to date.The methods of amniotic membrane preservation,the available commercial amniotic membrane products to date,and future directions for amniotic membrane use,including amniotic membrane extract eye drops(AMEED),are also discussed.It is paramount for ophthalmologists to stay up-to-date on the applications of AMT so as to effectively incorporate this versatile treatment modality into their practice,both in the operating room and in the clinic.By familiarizing the general ophthalmologist with its diverse applications,we hope to motivate general ophthalmologists to incorporate the use of AMT into their clinical practice,or provide guidance on how to recognize when referral to a corneal specialist for amniotic membrane application is prudent. 展开更多
关键词 Amniotic membrane epithelial defect CORNEA ocular surface reconstruction OPHTHALMOLOGY
下载PDF
多孔复合水凝胶负载角膜缘干细胞重建眼表
4
作者 王付燕 许悦荷 +5 位作者 石德鹏 程钧 赵龙 祁霞 周庆军 谢立信 《Science China Materials》 SCIE EI CAS CSCD 2024年第7期2103-2114,共12页
干细胞疗法是一种用于重建角膜缘干细胞缺乏症(LSCD)患者眼表的新技术.然而,目前报道的干细胞疗法治疗LSCD仅局限于二维(2D)培养体系,不能模拟干细胞在体内生存的原生微环境.本研究基于多孔明胶甲基丙烯酰(GelMA)/丝素蛋白甲基丙烯酸缩... 干细胞疗法是一种用于重建角膜缘干细胞缺乏症(LSCD)患者眼表的新技术.然而,目前报道的干细胞疗法治疗LSCD仅局限于二维(2D)培养体系,不能模拟干细胞在体内生存的原生微环境.本研究基于多孔明胶甲基丙烯酰(GelMA)/丝素蛋白甲基丙烯酸缩水甘油酯(SilMA),制备了一种可注射的光交联水凝胶用于负载角膜缘干细胞(LSCs)以重建眼表.多孔GelMA/SilMA水凝胶具有优异的透明度和良好的粘附性.更重要的是,该水凝胶保持了兔LSCs的活力,支持了兔LSCs的粘附,并促进了它们在体外3D培养环境中的迁移.蛋白质组学分析证实,多孔GelMA/SilMA水凝胶3D细胞培养体系能够保持LSCs的自我更新和分化能力.此外,组织学分析表明,负载LSCs的多孔GelMA/SilMA水凝胶能够有效的促进LSCD再上皮化.多孔水凝胶能够简化连续细胞培养的相关操作,以构建具有细胞均匀分布的眼表.这些发现为干细胞疗法和再生医学用于眼表重建提供了有价值的见解. 展开更多
关键词 porous gelatin silk fibroin HYDROGEL limbal stem cells ocular surface reconstruction
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部